SHANGHAI,Nov. 20,2024-- Epigenic Therapeutics,a leading biotechnology company dedicated to developing next-generation gene modulation therapy,today announced that it has received approval of clinical
TOKYO,Nov. 20,2024--TIER IV,the pioneering force behind the world\'s first open-source software for autonomous driving,is excited to announce the launch of Minibus 2.0,the latest addition to its fanf
Financial Donations Lead as Most Impactful Support Method Across Generations,but Volunteering and Advocacy Remain Vital
GUANGZHOU,China,Nov. 18,2024-- An evening gala celebrating the centennial of Sun Yat-sen University (SYSU) was held on November 12. Over 1,100 SYSU faculty members and students,together with alumni an
New report analyses Mainland China\'s transformation into a global biopharma powerhouse,with key insights for international stakeholders
6.2 additional kilometres with five new stations Up to 400,000 passengers per day and significantly reduced travel time
